Reported Aug 6, 2025 · Ongoing
Lorazepam Injection, USP, 2 mg/mL, 25 x 1mL vials/carton, Rx Only, Manufactured by: Hikma Berkeley Heights, NJ 07922,…
Hikma Pharmaceuticals USA Inc.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Hikma Pharmaceuticals USA Inc. · 2 Esterbrook Ln · Cherry Hill, NJ · 08003-4002
Is this the product you have?
- Lorazepam Injection, USP, 2 mg/mL, 25 x 1mL vials/carton, Rx Only
- Manufactured by
Hikma Berkeley HeightsNJ 07922NDC# 0641-6044-25
- Lot codes and dates
Lot # K24118exp. date 10/31/2026
- Amount recalled
- 382,775 1mL vials
Where it was sold
- Nationwide
Why it was recalled
Failed Impurities/Degradation Specifications: An out-of-Specification for total related compounds
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Hikma Pharmaceuticals USA Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.